Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - SELLAS Life Sciences Group, Inc. | b78743e10vk.htm |
| EX-23.1 - EX-23.1 - SELLAS Life Sciences Group, Inc. | b78743exv23w1.htm |
| EX-31.2 - EX-31.2 - SELLAS Life Sciences Group, Inc. | b78743exv31w2.htm |
| EX-31.1 - EX-31.1 - SELLAS Life Sciences Group, Inc. | b78743exv31w1.htm |
| EX-10.28 - EX-10.28 - SELLAS Life Sciences Group, Inc. | b78743exv10w28.htm |
| EX-10.27 - EX-10.27 - SELLAS Life Sciences Group, Inc. | b78743exv10w27.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED
PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned, as principal executive
officer and principal financial officer of RXi Pharmaceuticals Corporation (the “Company”), does
hereby certify that to such officer’s knowledge:
(1) the Company’s Form 10-K for the period ended December 31, 2009 fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Company’s Form 10-K for the period ended December 31, 2009
fairly presents, in all material respects, the financial condition and results of operations of the
Company.
| /s/ Noah Beerman | ||||
| Noah Beerman | ||||
| President and Chief Executive Officer (Principal Executive Officer) |
||||
| /s/ Amy Tata | ||||
| Amy Tata | ||||
| Principal Accounting Officer (Principal Financial and Accounting Officer) |
||||
Date: March 31, 2010